|Systematic (IUPAC) name|
|6-allyl-6-nor-lysergic acid diethylamide|
|Legal status||Controlled in the United States via the Federal Analog Act but only if it is intended for human consumption.|
| (what is this?)
AL-LAD, also known as 6-allyl-6-nor-lysergic acid diethylamide or allylysergamide, is a novel psychedelic drug and an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL (Tryptamines i Have Known And Loved). While AL-LAD has subtly different effects than LSD, and appears to be slightly shorter lasting, their potencies are similar; an active dose of AL-LAD is reported to be between 80 and 160 micrograms.
- Hoffman AJ, Nichols DE (September 1985). "Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives". Journal of Medicinal Chemistry 28 (9): 1252–5. doi:10.1021/jm00147a022. PMID 4032428.
- Shulgin, Alexander; Ann Shulgin (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press, 392. ISBN 0-9630096-9-9. OCLC 38503252.
- AL-LAD Thread. UKChemicalResearch.org
|This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it.|